| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697906 | Clinical Oncology | 2016 | 7 Pages |
Abstract
Chemo-IMRT for LA-NPC is feasible with good survival outcomes. At 1 year, 31% experience â¥grade 2 subjective xerostomia.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.B. Miah, S.A. Bhide, L. Del Rosario, J. Matthews, R. Nicol, M.A. Tanay, S. Gupta, S.H. Zaidi, K.L. Newbold, K.J. Harrington, C.M. Nutting,